Is Danaher Corporation (DHR) overvalued? · P/E 39, rev $24.57B
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
This page asks whether Danaher Corporation (DHR) looks expensive on cached numbers — not a short thesis.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next DHR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the DHR stock page for the full model, not this heading.
Not investment advice.